Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boers

Showing results (101-110 of 277) with videos related to

Pageof 28
Sort By:
Cephalalgia : an International Journal of Headache|October 19, 1999
Serotonin infusions inhibit sensory input from the dural vasculatureG A Lambert, T Shimomura, P M Boers, et al.
The Journal of Rheumatology|January 26, 1999
The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trialsZ Ortiz, B Shea, M Garcia Dieguez, et al.
Transplantation Proceedings|June 1, 1988
Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patientsM Boers, A W van Rijthoven, H S Goei Thè, et al.
The Journal of Rheumatology|January 26, 1999
Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for RheumatologyG Wells, M Boers, B Shea, et al.
The Journal of Rheumatology|July 1, 1995
Interactive conference voting. The OMERACT II Committee. Outcome Measures in Rheumatoid Arthritis Clinical Trial ConferenceC H Goldsmith, E Duku, P M Brooks, et al.
Seminars in Arthritis and Rheumatism|August 1, 1992
Cyclosporine in rheumatoid arthritisB A Dijkmans, A W van Rijthoven, H S Goei Thè, et al.
British Journal of Rheumatology|November 24, 1998
Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde ArtritisA C Verhoeven, J C Bibo, M Boers, et al.
The Journal of Rheumatology|March 15, 2001
Minimal clinically important differences: review of methodsG Wells, D Beaton, B Shea, et al.
The Netherlands Journal of Medicine|February 1, 1989
Shigellosis and AIDS. Report of a case and brief review of the literatureM Boers, A J Peeters, M van Berkel, et al.
The Journal of Rheumatology|January 26, 1999
Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in RheumatologyM Gazarian, P Tugwell, M Boers, et al.
Pageof 28

Showing results (101-110 of 277) with videos related to

Sort By:
Pageof 28
Cephalalgia : an International Journal of Headache|October 19, 1999
Serotonin infusions inhibit sensory input from the dural vasculatureG A Lambert, T Shimomura, P M Boers, et al.
The Journal of Rheumatology|January 26, 1999
The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trialsZ Ortiz, B Shea, M Garcia Dieguez, et al.
Transplantation Proceedings|June 1, 1988
Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patientsM Boers, A W van Rijthoven, H S Goei Thè, et al.
The Journal of Rheumatology|January 26, 1999
Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for RheumatologyG Wells, M Boers, B Shea, et al.
The Journal of Rheumatology|July 1, 1995
Interactive conference voting. The OMERACT II Committee. Outcome Measures in Rheumatoid Arthritis Clinical Trial ConferenceC H Goldsmith, E Duku, P M Brooks, et al.
Seminars in Arthritis and Rheumatism|August 1, 1992
Cyclosporine in rheumatoid arthritisB A Dijkmans, A W van Rijthoven, H S Goei Thè, et al.
British Journal of Rheumatology|November 24, 1998
Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde ArtritisA C Verhoeven, J C Bibo, M Boers, et al.
The Journal of Rheumatology|March 15, 2001
Minimal clinically important differences: review of methodsG Wells, D Beaton, B Shea, et al.
The Netherlands Journal of Medicine|February 1, 1989
Shigellosis and AIDS. Report of a case and brief review of the literatureM Boers, A J Peeters, M van Berkel, et al.
The Journal of Rheumatology|January 26, 1999
Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in RheumatologyM Gazarian, P Tugwell, M Boers, et al.
Pageof 28